A series of single-point variants in the unique β3-β4 loop of TRIO PH2 has been identified in patients with neurodevelopmental disorders (NDDs), but how they impact TRIO GEF2 activity is not known. This evidence concerns the gene GABARAPL2 and neurodevelopmental disorder.